Mayo Clinic Buys Cancer Genetics Inc, Sells ClearPoint Neuro Inc

Author's Avatar
[email protected]
Apr 24, 2020
Article's Main Image
Investment company Mayo Clinic (Current Portfolio) buys Cancer Genetics Inc, sells ClearPoint Neuro Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Mayo Clinic. As of 2020Q1, Mayo Clinic owns 6 stocks with a total value of $39 million. These are the details of the buys and sells.

For the details of Mayo Clinic's stock buys and sells, go to

These are the top 5 holdings of Mayo Clinic
  1. Black Stone Minerals LP (BSM) - 5,711,137 shares, 69.37% of the total portfolio. Shares added by 0.23%
  2. Unity Biotechnology Inc (UBX) - 1,571,981 shares, 23.66% of the total portfolio.
  3. Evelo Biosciences Inc (EVLO) - 484,953 shares, 4.73% of the total portfolio.
  4. Seres Therapeutics Inc (MCRB) - 180,000 shares, 1.67% of the total portfolio.
  5. Exact Sciences Corp (EXAS) - 3,795 shares, 0.57% of the total portfolio.
New Purchase: Cancer Genetics Inc (CGIX)

Mayo Clinic initiated holding in Cancer Genetics Inc. The purchase prices were between $2.09 and $5.96, with an estimated average price of $4.11. The stock is now traded at around $2.96. The impact to a portfolio due to this purchase was less than 0.01%. The holding were 444 shares as of .

Sold Out: ClearPoint Neuro Inc (CLPT)

Mayo Clinic sold out a holding in ClearPoint Neuro Inc. The sale prices were between $3.33 and $6.14, with an estimated average price of $4.94.

Here is the complete portfolio of Mayo Clinic. Also check out:

1. Mayo Clinic's Undervalued Stocks
2. Mayo Clinic's Top Growth Companies, and
3. Mayo Clinic's High Yield stocks
4. Stocks that Mayo Clinic keeps buying
0 / 5 (0 votes)